Cargando…
The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential
Cancer, in all its types and manifestations, remains one of the most frequent causes of death worldwide; an important number of anticancer drugs have been developed from plants, fungi and animals, starting with natural compounds that were later derivatized in order to achieve an optimized pharmacoki...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697306/ https://www.ncbi.nlm.nih.gov/pubmed/36431906 http://dx.doi.org/10.3390/molecules27227807 |
_version_ | 1784838529316028416 |
---|---|
author | Nistor, Gabriela Mioc, Marius Mioc, Alexandra Balan-Porcarasu, Mihaela Racoviceanu, Roxana Prodea, Alexandra Milan, Andreea Ghiulai, Roxana Semenescu, Alexandra Dehelean, Cristina Șoica, Codruța |
author_facet | Nistor, Gabriela Mioc, Marius Mioc, Alexandra Balan-Porcarasu, Mihaela Racoviceanu, Roxana Prodea, Alexandra Milan, Andreea Ghiulai, Roxana Semenescu, Alexandra Dehelean, Cristina Șoica, Codruța |
author_sort | Nistor, Gabriela |
collection | PubMed |
description | Cancer, in all its types and manifestations, remains one of the most frequent causes of death worldwide; an important number of anticancer drugs have been developed from plants, fungi and animals, starting with natural compounds that were later derivatized in order to achieve an optimized pharmacokinetic/pharmacological profile. Betulinic acid is a pentacyclic triterpenic compound that was identified as an anticancer agent whose main advantage consists in its selective activity, which ensures the almost total lack of cytotoxic side effects. Conjugates of betulinic acid with substituted triazoles, scaffolds with significant pharmacological properties, were synthesized and tested as anticancer agents in order to achieve new therapeutic alternatives. The current paper aims to obtain a C30-1,2,4-triazole derivative of betulinic acid simultaneously acetylated at C3 whose biological activity was tested against RPMI melanoma cells. The compound revealed significant cytotoxic effects at the tested concentrations (2, 10 and 50 μΜ) by significantly decreasing the cell viability to 88.3%, 54.7% and 24.5%, respectively, as compared to the control. The compound’s testing in normal HaCaT cells showed a lack of toxicity, which indicates its selective dose-dependent anticancer activity. The investigation of its underlying molecular mechanism revealed an apoptotic effect induced at the mitochondrial level, which was validated through high-resolution respirometry studies. |
format | Online Article Text |
id | pubmed-9697306 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96973062022-11-26 The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential Nistor, Gabriela Mioc, Marius Mioc, Alexandra Balan-Porcarasu, Mihaela Racoviceanu, Roxana Prodea, Alexandra Milan, Andreea Ghiulai, Roxana Semenescu, Alexandra Dehelean, Cristina Șoica, Codruța Molecules Article Cancer, in all its types and manifestations, remains one of the most frequent causes of death worldwide; an important number of anticancer drugs have been developed from plants, fungi and animals, starting with natural compounds that were later derivatized in order to achieve an optimized pharmacokinetic/pharmacological profile. Betulinic acid is a pentacyclic triterpenic compound that was identified as an anticancer agent whose main advantage consists in its selective activity, which ensures the almost total lack of cytotoxic side effects. Conjugates of betulinic acid with substituted triazoles, scaffolds with significant pharmacological properties, were synthesized and tested as anticancer agents in order to achieve new therapeutic alternatives. The current paper aims to obtain a C30-1,2,4-triazole derivative of betulinic acid simultaneously acetylated at C3 whose biological activity was tested against RPMI melanoma cells. The compound revealed significant cytotoxic effects at the tested concentrations (2, 10 and 50 μΜ) by significantly decreasing the cell viability to 88.3%, 54.7% and 24.5%, respectively, as compared to the control. The compound’s testing in normal HaCaT cells showed a lack of toxicity, which indicates its selective dose-dependent anticancer activity. The investigation of its underlying molecular mechanism revealed an apoptotic effect induced at the mitochondrial level, which was validated through high-resolution respirometry studies. MDPI 2022-11-12 /pmc/articles/PMC9697306/ /pubmed/36431906 http://dx.doi.org/10.3390/molecules27227807 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nistor, Gabriela Mioc, Marius Mioc, Alexandra Balan-Porcarasu, Mihaela Racoviceanu, Roxana Prodea, Alexandra Milan, Andreea Ghiulai, Roxana Semenescu, Alexandra Dehelean, Cristina Șoica, Codruța The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential |
title | The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential |
title_full | The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential |
title_fullStr | The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential |
title_full_unstemmed | The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential |
title_short | The C30-Modulation of Betulinic Acid Using 1,2,4-Triazole: A Promising Strategy for Increasing Its Antimelanoma Cytotoxic Potential |
title_sort | c30-modulation of betulinic acid using 1,2,4-triazole: a promising strategy for increasing its antimelanoma cytotoxic potential |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9697306/ https://www.ncbi.nlm.nih.gov/pubmed/36431906 http://dx.doi.org/10.3390/molecules27227807 |
work_keys_str_mv | AT nistorgabriela thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT miocmarius thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT miocalexandra thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT balanporcarasumihaela thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT racoviceanuroxana thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT prodeaalexandra thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT milanandreea thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT ghiulairoxana thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT semenescualexandra thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT deheleancristina thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT soicacodruta thec30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT nistorgabriela c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT miocmarius c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT miocalexandra c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT balanporcarasumihaela c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT racoviceanuroxana c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT prodeaalexandra c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT milanandreea c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT ghiulairoxana c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT semenescualexandra c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT deheleancristina c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential AT soicacodruta c30modulationofbetulinicacidusing124triazoleapromisingstrategyforincreasingitsantimelanomacytotoxicpotential |